Skip to main content

Prototype Prescribing Outlier Dashboard for Market Weighton Group Practice

At OpenPrescribing we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support prescribers and organisations to audit and review prescribing. These pilot results are provided for the interest of advanced users, although we don't know how relevant they are in practice. There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to explain.

The DataLab is keen to hear your feedback on the results. You can do this by completing the following survey or emailing us at [email protected]. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed feedback.

This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical in the BNF coding system, the count of all prescriptions within that chemical's BNF subparagraph, for prescriptions dispensed between June 2021 and December 2021. We then calculate the ratio of these counts along with the mean and standard deviation of those ratios across all Practices. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given Practice is from the population mean. We then rank your “z-scores” to find the top 10 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.

For each outlier chemical, a kernel density estimation plot of all Practice's chemical:subparagraph ratios is provided, with this Practice's ratio overlaid in red.

It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not, to inform research on this topic. Our full analytical method code is openly available on GitHub here.

This is a new, experimental feature. We'd love to .

Prescribing where Market Weighton Group Practice is higher than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Vildagliptin 154 Other antidiabetic drugs 1,408 0.11 0.00 0.01 12.55
Chlorhex hydrochloride 4 Preparations for minor cuts and abrasions 6 0.67 0.01 0.08 8.58
Mometasone/glycopyrronium/indacaterol 6 Corticosteroids (respiratory) 2,655 0.00 0.00 0.00 8.32
Loperamide hydrochloride and simeticone 12 Antimotility drugs 205 0.06 0.00 0.01 7.88
Guanfacine 34 CNS Stimulants and drugs used for ADHD 94 0.36 0.02 0.05 6.71
Diamorphine hydrochloride (Systemic) 25 Opioid analgesics 2,660 0.01 0.00 0.00 4.84
Olmesartan medoxomil/amlodipine 40 Angiotensin-II receptor antagonists 2,726 0.01 0.00 0.00 4.67
Arachis oil 1 Shampoos and some other scalp preparations 155 0.01 0.00 0.00 3.78
Carvedilol 296 Beta-adrenoceptor blocking drugs 5,113 0.06 0.01 0.01 3.56
Indacaterol maleate 18 Selective beta(2)-agonists 3,089 0.01 0.00 0.00 3.38

Prescribing where Market Weighton Group Practice is lower than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Loperamide hydrochloride 193 Antimotility drugs 205 0.94 1.00 0.01 -5.27
Zopiclone 187 Hypnotics 542 0.35 0.60 0.14 -1.87
Sumatriptan succinate 270 Treatment of acute migraine 598 0.45 0.67 0.12 -1.81
Neomycin sulfate 21 Nasal preparations for infection 35 0.60 0.84 0.14 -1.73
Spironolactone 238 Potassium-sparing diuretics and aldosterone antagonists 477 0.50 0.72 0.14 -1.59
Other multivitamin preparations 45 Multivitamin preparations 89 0.51 0.82 0.21 -1.53
Combined ethinylestradiol 20mcg 14 Combined hormonal contraceptives 492 0.03 0.12 0.06 -1.48
Methylphenidate hydrochloride 34 CNS Stimulants and drugs used for ADHD 94 0.36 0.65 0.20 -1.41
Sildenafil (Erectile Dysfunction) 418 Drugs for erectile dysfunction 651 0.64 0.77 0.09 -1.35
Miconazole nitrate 10 Antifungal preparations 103 0.10 0.27 0.13 -1.34